Historique
Article de Périodique
Does the perception of risk associated with psychedelics use differ in physicians according to their belief of effectiveness? (2026)
Auteur(s) :
BEZO, A. ;
ROMEO, B. ;
LE STRAT, Y. ;
STRIKA-BRUNEAU, L. ;
BENYAMINA, A. ;
HERMAND, M.
Année
2026
Page(s) :
1-6
Langue(s) :
Anglais
Domaine :
Drogues illicites
Thésaurus géographique
FRANCE
Thésaurus mots-clés
HALLUCINOGENES
;
PERCEPTION
;
MEDECIN
;
PSYCHIATRIE
;
FACTEUR DE RISQUE
;
CROYANCE
;
EFFICACITE
;
AUTOMUTILATION
;
AGRESSIVITE
;
PERSONNEL MEDICAL
;
USAGE THERAPEUTIQUE
;
REPRESENTATION SOCIALE
;
ETUDE TRANSVERSALE
Résumé :
The aim of this study was to explore the perception of psychedelics within the medical population. Participants were asked by questionnaire about the potential of abuse, the somatic and psychiatric complications, and the risks of self-harm and aggression associated with the use of psychedelics using Likert Scales. A total of 407 participants were included. In our sample, the following means were found: 3.05 for general risk (<.001), 2.68 for self-harm risk (<.001), 2.47 for aggression (<.001), 2.71 for addictive risk (< .001), 2.76 for psychiatric disorder risk (<.001), and 2.11 for somatic disorder(< .001). Physicians from the lower mean of age were significantly more supportive of therapeutic potential, while general practitioners were significantly less likely to consider psychedelics as a treatment than specialists (<.001). By the term therapeutic potential, we meant the therapeutic value attributable to psychedelics and the risks expressed the possibility of damage caused by the use of the drug. Clinicians who considered psychedelics as a potential treatment were less likely to associate these with risks than their counterparts (<.001). The results of this study show that the perception of the danger of psychedelic use was important in the medical community in France. [Author's abstract]
Affiliation :
Department of Psychiatry and Addictology, APHP, Paul Brousse Hospital, Villejuif, France.
Unité de Recherche Psychiatrie-Comorbidités-Addictions - PSYCOMADD - Paris Saclay University Île-de-France,Villejuif, France.
Department of Psychiatry AP-HP, Louis Mourier Hospital, Colombes, France.
Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Unité de Recherche Psychiatrie-Comorbidités-Addictions - PSYCOMADD - Paris Saclay University Île-de-France,Villejuif, France.
Department of Psychiatry AP-HP, Louis Mourier Hospital, Colombes, France.
Supportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Cote :
Abonnement